225 related articles for article (PubMed ID: 12711157)
1. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
2. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
[TBL] [Abstract][Full Text] [Related]
3. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
4. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
5. [Study on pulmonary delivery of peptide drugs in rats: effects of absorption enhancers on cellular membrane fluidity].
Wang ZY; Zhang Q
Yao Xue Xue Bao; 2003 Dec; 38(12):957-61. PubMed ID: 15040095
[TBL] [Abstract][Full Text] [Related]
6. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Hinchcliffe M; Jabbal-Gill I; Smith A
J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
Na L; Mao S; Wang J; Sun W
Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
10. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
Schipper NG; Verhoef JC; De Lannoy LM; Romeijn SG; Brakkee JH; Wiegant VM; Gispen WH; Merkus FW
Br J Pharmacol; 1993 Dec; 110(4):1335-40. PubMed ID: 8306072
[TBL] [Abstract][Full Text] [Related]
11. Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
Hermens WA; Deurloo MJ; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1990 May; 7(5):500-3. PubMed ID: 2367318
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.
Shao Z; Li Y; Chermak T; Mitra AK
Pharm Res; 1994 Aug; 11(8):1174-9. PubMed ID: 7971720
[TBL] [Abstract][Full Text] [Related]
13. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
du Plessis LH; Lubbe J; Strauss T; Kotzé AF
Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in rats.
Kagatani S; Shinoda T; Fukui M; Ohmura T; Hasumi S; Sonobe T
Pharm Res; 1996 May; 13(5):739-43. PubMed ID: 8860430
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
[TBL] [Abstract][Full Text] [Related]
17. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
[TBL] [Abstract][Full Text] [Related]
18. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
19. The influence of the enhancer dimyristoylphosphatidylglycerol and formulation factors on the nasal absorption of salmon calcitonin.
Dua R; Duncan M; Zia H; Needham TE
Drug Deliv; 1998; 5(2):127-34. PubMed ID: 19570004
[TBL] [Abstract][Full Text] [Related]
20. [Promoting mechanism of enhancers and transport pathway of large hydrophilic molecular across nasal epithelium studied by ESR and CLSM technologies].
Zhang YJ; Zhang Q; Yang J; Sun MJ; Wang XL; Chen MX; Wang Q; Jiang H
Yao Xue Xue Bao; 2007 Nov; 42(11):1195-200. PubMed ID: 18300478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
